BRD2 directly regulates multiple TH17-associated cytokines, including IL17, IL21, and GMCSF32, and altered TH17 cells mediate autoimmune conditions, including multiple sclerosis, psoriasis, rheumatoid arthritis, and CD32. Here, BRD2 is linked to rheumatoid arthritis.